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Expanding Magnetic Resonance Imaging Access for Patients with Cardiovascular Implantable
Electronic Devices
Abstract
Problem. Patients with non-conditional cardiovascular implantable electronic devices (CIEDs),
which lack magnetic resonance imaging (MRI) components, are unable to undergo MRI.
Context. The Heart Rhythm Society guidelines for patient device management and Centers for
Medicare and Medicaid Services requirements for persons with specific expertise in implanted
permanent devices to manage CIEDs during MRI spurred policy, procedure and staffing
changes.
Interventions. The evidence-based change-of-practice project comprised of workflow
development, policy and procedure changes, implementation of required staffing support to
manage the CIED during an MRI.
Measures: The outcome measure was to improve access to MRI for patients with CIEDs,
measured through data extracted from the Clinical Business Analytics reporting tool. Three
process measures determined the change in numbers of patients presenting for, excluded from, or
receiving MRIs as a consequence of the intervention.
Results. CIED MRI workflows and the revised policy and procedure were finalized. Since
implementation of extended hours of CIED support on October 7, 2019, the arrhythmia NP has
supervised 18 MRIs after 5 pm.
Conclusions. The project expanded MRI access and CIED management support for all patients,
ensuring high-quality care aligned with institutional standards and government regulations.

EXPANDING MAGNETIC RESONANCE ACCESS
Keywords: magnetic resonance imaging/MRI, cardiac implantable electronic devices/CIED,
MRI safety, MRI adverse effects, CIED interference, pacemaker, implantable cardioverter
defibrillator.
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Section II. Introduction
Problem Description
The healthcare organization selected for this project is a large academic medical center
(AMC). The stakeholders for this project include the arrhythmia, neurology, and radiology
leadership teams, medical directors, arrhythmia nurse practitioners (NPs), neurology, and
radiology staff. The Doctorate in Nursing Practice (DNP) student is a member of the
Cardiovascular Health (CVH) Service Line leadership team and is working with the stakeholders
and department team members on this improvement project. The AMC was slow to adopt the
2017 Heart Rhythm Society (HRS) non-conditional device management guidelines. The AMC’s
CIED MRI policy and procedure addressed only the oversight of conditional CIEDs, therefore
limiting the arrhythmia team’s scope of service. The arrhythmia team was not assisting in the
supervision of non-conditional CIEDs during magnetic resonance imaging (MRI). The AMC’s
arrhythmia physicians needed more evidence-based data demonstrating the safety of MRIs for
patients with non-conditional CIEDs in order to agree to provide MRIs for these patients. The
current arrhythmia staffing model could not support adding MRI services for patients even if the
physicians agreed to do so.
In January 2018, the Centers for Medicare and Medicaid Services (CMS) proposed
changes in the management and supervision of patients with CIEDs who require MRIs. CMS
requires that a qualified physician, NP, or physician assistant (PA) with expertise in implanted
permanent pacemakers (PM), implantable cardioverter defibrillator (ICD), cardiac
resynchronization therapy pacemakers (CRT-P), or cardiac resynchronization therapy
defibrillators (CRT-D) must directly supervise patients with CIEDs during an MRI. Despite
HRS’s recent consensus statement and CMS’s staffing requirements supporting the supervision
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of non-conditional CIEDs, the AMC had not yet taken steps to provide device management for
patients with non-conditional CIEDs.
In 2017, the neurology team conducted a retrospective chart review of patients 18 years
or older who had received an inpatient neurology consultation for conditions warranting a brain
MRI and who had a pre-existing non-conditional CIED. The neurology team concluded that on
average 2.5 patients per month presented with an acute neurological condition and did not
receive an MRI because of their non-conditional CIED. These patients were referred to other
testing methods or sent to another facility to complete the MRI. The number of patients being
deferred an MRI was reported to the arrhythmia and radiology leadership teams, where critical
patient safety concerns were raised.
The AMC did not have standardized CIED MRI safety protocols and workflows in
place. The DNP project included the development of CIED management workflows for MR
non-conditional CIEDs, updating the device management policy and procedure, as well as
defining and implementing safe staffing support to deliver CIED management during an
MRI. After months of collaboration, the systematic workflows created by the arrhythmia team to
support the management of non-conditional and urgent requests were approved by the
arrhythmia, neurology, and radiology teams. Implementation of these workflows was dependent
on the development of an arrhythmia team-staffing plan to facilitate and provide appropriate
clinical support for these patients. The arrhythmia, neurology, and radiology teams worked
collaboratively to assess and develop a staffing model to address the Centers for Medicare and
Medicaid Services (CMS) requirements.
The importance of this improvement project is the promotion of safety protocols and
adherence to CMS guidelines. Nurses play a critical role in ensuring safe patient practice,
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understanding care processes and facilitating efficient workflows. This project was supported by
the AMC and deemed one of significant scope (see Appendix A). The DNP project included the
development of CIED management workflows for MR non-conditional CIEDs, updating the
device management policy and procedure, as well as defining and implementing safe staffing
support to deliver CIED management during an MRI.
Available Knowledge
PICOT question. For patients who need an MRI and have a CIED, how does the
application of nationally recommended staffing standards compare to the current device
management support improve patient access and throughput by October 7, 2019?
Literature review. The PICOT question guided a systematic search and a
comprehensive review of the literature using the following search terms: magnetic resonance
imaging, cardiac implantable electronic devices, MRI, MRI safety, MRI adverse effects, CIED,
CIED interference, pacemaker, and implantable cardioverter defibrillator. The following
databases were accessed to search for relevant literature: Cochrane, CINAHL, PubMed,
Evidence-Based Journals, Scopus, Medscape, Heart Rhythm Society, and American Heart
Association. The search yielded 30 articles from which 12 were selected. Articles were selected
if they addressed CIEDs, MRIs, safety, safety concerns, were written in the English language,
and were published between 2011 and 2018. Inclusion criteria were: MRI safety protocol, MRI
magnetic strength, and conditional and non-conditional CIEDs. Articles were excluded if they
were focused only on a product from one manufacturer.
Articles were critically appraised with the Johns Hopkins Nursing Evidence-Based
Practice Non-Research and Research Evidence Appraisal Tools (Dang & Dearholt, 2018). These
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tools provided a concise appraisal of the level and quality of the evidence. Articles were chosen
based on the strength and quality of research evidence.
Two of the nine studies were prospective, single non-randomized studies. The study by
Nazarian et al. (2017) and Bailey et al. (2016) reviewed conditional and non-conditional CIED
interrogation results before and after the MRI with the utilization of a standardized device
management protocol. Device interrogation with lead comparison was performed at enrollment,
pre- and post-MRI scan, one-month post-MRI, and three-month post-MRI. Both studies
compared the effects of thoracic and non-thoracic MRI on CIEDs. The results of these studies
demonstrated no long-term clinically significant adverse events were associated with the MRIs.
Limitations included small sample sizes and low number of cardiac MRIs. Based on the Johns
Hopkins Research Evidence Appraisal Tool, both studies were rated II-A.
Two prospective, multicenter cohort studies by Jung, Sebastian, and Zvereva (2015) and
Russo et al. (2017) analyzed CIED interrogation results before and after an MRI with the
utilization of a standardized protocol. All studies were performed in a 1.5 tesla (T) MRI scanner.
The study by Jung, Sebastian, and Zvereva (2015) identified the prospective adverse event rate
and parameter changes in non-MRI CIEDs using a device registry and determined that the MRI
risk was low. Russo et al. (2017) analyzed PM and ICD data and confirmed the safety of nonMRI conditional CIEDs who underwent clinically indicated non-thoracic MRI at 1.5T. Device
or lead failure did not occur in both studies at 1.5T but was not predictive of findings with testing
at higher magnetic strength, up to 3T. Both studies were rated III A/B using the Johns Hopkins
Research Evidence Appraisal Tool.
In the studies chosen, the one retrospective cohort study by Dandamudi et al. (2016)
reviewed the device assessment reports in the electronic medical records of patients with CIEDs
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before and after an MRI performed according to a CIED safety protocol. When a comprehensive
CIED MRI protocol was followed, the risk of performing 1.5T MRI with the device in the
isocenter, including PM dependent patients was low. There were no significant changes in atrial
and ventricular sensing impedance, and threshold measurements. There were no episodes of
device mode changes, arrhythmias, therapies delivered, electrical reset, or battery depletion.
This study is appraised as III A/B per the Johns Hopkins Research Evidence Appraisal Tool.
One prospective cohort study by Yadava et al. (2017) reviewed 277 patients who had
undergone 293 scans. The CIEDs included 170 PMs and 71 ICDs. Devices were interrogated
before and after the MRI with the use of a standardized protocol. The study demonstrated no
changes in device settings during an MRI. Long-term follow-up device assessment confirmed no
adverse effects from 1.5T MRI. According to the Johns Hopkins Research Evidence Appraisal
Tool, both studies were rated III A/B.
Two randomized control trials (RCT) by Shenthar et al. (2015) and Wilkoff et al. (2011)
analyzed CIEDs before, during, and after the MRI with the use of an MRI scan protocol. The
study by Shenthar et al. (2015), evaluated MRI safety without positioning restrictions in patients
with MR conditional PM with non-MR conditional leads. Two hundred sixty-six patients were
sampled with a two to one ratio to the MRI group or control group. There were no related
complications immediately post or at one-month post-MRI. The second RCT by Wilkoff et al.
(2011) evaluated PM performance and pacing capture threshold nine to twelve weeks prior to the
MRI, during the MRI, and immediately after the MRI. Four hundred sixty-four patients were
randomized to undergo an MRI scan between nine to twelve weeks of post-CIED
implantation. Patients were monitored for arrhythmias, symptoms, and PM system function
during fourteen non-clinically indicated brain and lumbar MRI sequences. It was found that no
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MRI related complications occurred during or after the MRI. Based on the Johns Hopkins
Research Evidence Appraisal Tool, both studies were rated I-A.
One meta-analysis and systematic review performed by Shah et al. (2018) utilized a
random-effects model for meta-analysis of continuous variables including device lead parameters
such as capture threshold, sensing, and impedance; high-voltage ICD lead impedance, and
battery voltage change. Safety outcomes were evaluated with descriptive analysis. Indexed
articles from PubMed were queried between the years 1990-2017. The search yielded one
thousand three hundred twenty-four records to review. Seventy studies were included for the
systematic review, and five thousand ninety-nine patients were identified. The brain or cervical
spine was imaged the most and thoracic imaging was completed in seven hundred seventy-three
patients. The meta-analysis cohort included thirty-one studies. This analysis summarized the
safety profile of five thousand nine-hundred eight MRI studies in five thousand ninety-nine
patients with non-MRI conditional CIEDs in a span of twenty-five years. There were no
reported deaths and three total lead failures. There were no relevant changes in lead, battery, or
pulse generator performance. The observed changes were small, and inter-study variance was
low. The findings suggested the need for ongoing monitoring. Per the Johns Hopkins Research
Evidence Appraisal Tool, the study was rated III A/B.
Viera, Lazoura, Nicol, Rubens, and Padley (2013) analyzed data from a multicenter
device registry. Devices were interrogated before and after an MRI with the use of a
standardized protocol. The technical report confirmed the need for utilization of a
comprehensive safety protocol and substantiated the development of new generation MRI
conditional CIEDs. According to the Johns Hopkins Research Evidence Appraisal Tool, the
study was rated III A/B.
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A clinical review by Nordbeck, Ertl, and Ritter (2015) provided a better understanding of
the structures responsible for life-threatening complications as well as technical advances
supporting the safety of MRIs for CIEDs. Clinical trials were reviewed over the last twenty
years, including fourteen PM and thirteen ICD studies. The studies assessed the outcome in 1.5T
scanners and reported there were no adverse events. This was the only abstract found in the
literature review that demonstrated CIED safety during an MRI with appropriate monitoring and
application of a safety protocol. It attempted to offer an up-to-date and clinically useful
summary for practicing cardiologists. Based on the Johns Hopkins Research Evidence Appraisal
Tool, the study was rated III A/B.
In summary, the literature between 2011 and 2018 showed non-conditional CIEDs
undergoing 1.5T MRI had been evaluated pre, intra, and post MRI and demonstrated minimal to
no MRI-related complications or adverse effects. A CIED safety protocol was utilized in all the
studies. Many of the studies reported CIED reprogramming before and after the MRI. The
clinical review supported the utilization of appropriate monitoring and a safety protocol for
CIEDs during an MRI.
Findings from all the studies support the safety of an MRI for patients with conditional as
well as non-conditional CIEDs at the magnetic strength of 1.5T and validated the 2017 HRS
consensus statement demonstrated in the evaluation table (see Appendix B). MRIs were
performed with appropriate monitoring and the utilization of a safety protocol. Based on the
literature, more research is needed to evaluate the safety of MRIs at higher magnetic strength,
greater than 1.5T. Studies were limited due to the utilization of 1.5T magnetic strength. Several
studies had small sample sizes. The studies by Yadava et al. (2017) and Nazarian et al. (2017)
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could not accurately obtain follow-up device data because patients were referred by outside
physicians or patients were lost to follow-up.
Rationale
Conceptual framework. The conceptual framework for this project was a combination
of complexity theory and change theory. Complexity theory analyzes complex systems, strives
to understand their structure and purpose, and recognizes the importance of inter-relationships
and context (Litaker, Tomolo, Liberatore, Stange, & Aron, 2006). Complexity theory relates to
organizational theory through understanding how organizations adapt to their environment and
their coping mechanisms. In quality improvement, complexity theory thinking is utilized in
understanding how individuals and organizations adapt to an uncertain environment while they
respond to change-initiating events. Complexity theory asserts that people and organizations are
non-linear and complex adaptive systems (Grossman & Valiga, 2013). This framework was
suitable for the implementation of a comprehensive CIED MRI workflow algorithm and staffing
model. The AMC can be treated as a complex adaptive system exhibiting emergence,
complexity, chaos, self-organization, and interdependence.
Kurt Lewin developed the change theory of nursing and defined behavior as a dynamic
balance of forces working in opposite directions (Batras, Duff, & Smith, 2014). Lewin’s change
theory allowed the evaluation of group behavior and involved understanding its complexity and
influence on observed behaviors (Batras, Duff, & Smith, 2014). Health care providers
facilitating change integrate this theory into the development of interventions. Lewin designed a
three-step model for change: unfreezing, moving (change), and refreezing, Unfreezing involves
creating uneasiness with the status quo, represented in the neurology study that concluded 2.5
patients per month did not receive an MRI because of their non-conditional CIED. It is also
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demonstrated in the development of the NP staffing model based on CMS guidelines. Moving is
the act of change, the implementation of the proposed workflows and NP staffing model.
Refreezing is when change becomes the norm, demonstrated in the supervision and management
for all patients with CIEDs during an MRI.
Specific Aims
The goal of this project was to maintain high-quality care and comply with CMS
guidelines and national and institutional standards by extending NP service coverage to support
CIED management during an MRI. The specific aim of the DNP led evidence-based project was
to improve MRI access for all patients with CIEDs through the policy and procedure revision,
creation of standardized workflows, and extension of hours for MRI by October 7, 2019.
Section III: Methods
Context
This quality improvement project promotes patient safety and throughput by providing
access and the necessary care for all patients who have CIEDs and need MRIs. The key
stakeholders for this project include arrhythmia, neurology, and radiology leadership teams,
medical directors, arrhythmia NPs; and neurology, and radiology staff. All teams were aware of
the need for change.
CMS provided clear guidelines in the supervision of the CIED during an MRI. To
promote patient safety and align with best practices, it was necessary to support this
endeavor. Non-compliance with the recommended guidelines poses risks to patient safety and
potential liability. Per Wikman-Svahn and Lindblom (2018), the interpretation of risk magnifies
ethical issues. Providing NP CIED management during an MRI minimizes the potential patient
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safety risk concerns. The perspective of risks as probabilities and consequences is utilized in
risk-benefit- analysis in healthcare organizations (Wikman-Svahn & Lindblom, 2018).
After the findings from the AMC’s neurology retrospective, one-time chart review was
brought to the arrhythmia and radiology teams, a collective decision involving all stakeholders
was made to create a plan supporting the safe facilitation of MRIs for patients with CIEDs. The
neurology team utilized a patient data analytics tool to identify patients with the diagnosis of
stroke, transient ischemic attack (TIA), or acute neurological symptoms and had a CIED. Those
patients were cross-referenced with a CIED database to determine the conditionality of their
CIED. The outcome demonstrated that approximately 2.5 patients per month did not receive
MRIs since they had non-conditional CIEDs. In January 2019, the radiology team requested a
clinical and business analytics (CBA) report to identify all patients who needed MRIs and had
CIEDs. The report demonstrated from January to October there were 350 conditional and nonconditional CIED MRI requests, 33% were patients with neurological conditions. This data
further validated the need for CIED management during an MRI.
Adherence to the recommendations and staffing requirements of the 2018 CMS device
management guidelines was necessary for reimbursement. The arrhythmia team expressed
concerns that they could not adhere to the CIED management guidelines since they did not have
enough NPs to support device management for all patients with conditional and non-conditional
CIEDs. Although the MRI department has two suites that have the capacity to provide 1.5T
magnetic strength, only one was being utilized for complex cardiac cases, thus impeding access.
Extending weekly NP device management support for all CIEDs would enable imaging to
accommodate three to four additional MRI cases per day (21-28 per week). Additional NP FTEs
were necessary to implement extended hours of service. To reduce the direct cost of adding NPs
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for the extended hours, the NPs would also assist in Catheterization Angiography Laboratory
(Cath Lab) procedures and provide cardiovascular consultations throughout the hospital.
Intervention
The evidence-based change-of-practice project comprised of policy and procedure
changes, standardization of workflows, maximizing equipment utilization and availability,
modification of MRI scheduling, and implementation of required staffing support to manage the
CIED during an MRI. Policy and procedure revisions were necessary to allow NPs to practice
within their scope. Standardizing workflows for CIED MRI management was fundamental for
consistent care. The utilization of a second MRI suite and access to CIED programmers was
necessary to increase service capabilities. Creating a patient scheduling process was necessary to
promote concise communication between the radiology and arrhythmia teams. Developing a
staffing model was mandatory to comply with CMS requirements.
Study of the Intervention
Gap analysis. A gap analysis was conducted to identify inconsistencies. The MRI
department had one dedicated day to schedule and perform one to two MRI studies for complex
cardiology cases, which included patients with non-conditional CIEDs (see Appendix C). Prior
to the intervention, the arrhythmia NP team did not have a standardized workflow or a staffing
model to provide consistent CIED supervision during an MRI. The MRI department did not
have the device management programmers conveniently stored in the department, creating an
inefficient workflow for the arrhythmia team. The arrhythmia team had to find the programmer
in the clinic and transport it to the MRI department. The MRI scheduling process specific to
non-conditional CIEDs did not exist. Prior to the intervention, the state of this service was
inefficient and inconsistent, creating delays in patient care.
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Gantt chart. An action plan and timeline specific to this project are shown on the Gantt
chart (see Appendix D). This tool defined the path necessary for the completion of the
improvement activity, provided a foundation for scheduling tasks, and was useful in managing
the project’s activity schedule. The initial stages of the project began in early January 2018,
when the project was identified. Once the proposed project was approved by the DNP chair,
tasks such as creating an AIM statement, identification of stakeholders, and confirming baseline
metrics to support the need of this improvement project were determined. The project plan,
work breakdown structure, and the business plan were finalized in May 2018. In the fall of
2018, the business plan was presented in a situation, background, analysis or assessment, and
recommendations (SBAR) format to our leadership teams and stakeholders (see Appendix E).
The business plan was approved in January 2019. The development of the electronic document
workflow and a screening tool was finalized in January 2019 (see Appendix F). In January 2019,
the CIED MRI policy and procedure were finalized, and the NP staffing plan confirmed.
Arrhythmia NP recruitment began in February, with three of the 4.5 NP FTEs hired by August
2019 (see Appendix G). The goal was to implement the extended NP coverage by early October
2019. During the fall and winter of 2019, the teams will continue to have touch point meetings
to discuss any post-implementation issues with the new staffing model and conduct a plan, do,
study, act (PDSA) to evaluate the intervention (see Appendix H). A similar retrospective chart
review utilizing the CBA report to collect data on patients who require an MRI and have a CIED
will continue to be performed. The DNP student will monitor, analyze, and evaluate the
outcomes closely post-intervention to determine if the goal of having no patients turned away for
an MRI is achieved. Mitigation plans will be discussed, developed, implemented, and evaluated.
Once data is received, the outcomes will be presented to the teams and stakeholders.
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Work breakdown structure. The work breakdown structure (WBS) for this project
organized the deliverables into sections (see Appendix I). It was used as a communication tool
to supplement the Gantt chart. It defined the scope of our project and allowed oversight of each
task. The WBS had a hierarchical composition of the range of the project. There were three
levels in this project’s WBS. Planning and oversight involved developing the project plan,
creating a project charter, and performing a gap analysis demonstrated in the four quadrant A3.
The budget and business plan identified accountability, staffing needs, projected volumes, return
on investment, and implementation costs. Education was associated with performing literature
reviews and educational sessions with staff. Resources comprised of tasks such as reviewing
HRS workflow recommendations and CMS staffing guidelines, comparing staffing and device
management workflows from other organizations, and approval of the business plan. The staff
category included the recruitment and hiring of NPs, proposal of a staffing plan and schedule,
onboarding of NPs, and vetting schedules with the team and stakeholders. The implementation
of intervention consisted of confirmation of NP extended hours’ schedule, workflow review,
monitoring of intervention, performing PDSA cycles if needed, and comparing data pre- and
post-intervention.
Responsibility/Communication plan. As one of the team leaders of this project, the
DNP student maintained oversight of the project and reported the progress of the intervention
during scheduled meetings and via email. Maintaining accountability and communication was
necessary to align with AMC’s current organizational process and structure. The project
improvement team included staff nurses, MRI technicians, NPs, department managers, medical
directors, and department directors. Reporting of this project’s findings and results to the team
and stakeholders occurred after meetings and milestone completion (see Appendix J). Post-
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implementation data reports were initiated on October 7, 2019 and will continue weekly for one
month, monthly for three months, quarterly for one year, and then yearly thereafter.
SWOT analysis. The strengths, weaknesses, opportunities, and threats (SWOT) analysis
(see Appendix K) enabled the DNP student to identify the challenges in meeting the specific
project aim. The strengths of this project included the improvement of patient throughput and
access, patient satisfaction, promoting patient safety, compliance with CMS staffing guidelines,
creation of an updated CIED MRI policy and procedure, development of electronic
documentation workflows, and providing a revenue-generating service. The only weakness
identified was the MRI management support was only available for patients who presented with
acute neurological conditions. Opportunities included serving the non-neurological patients who
need an MRI and have a non-conditional CIED, and creating an extended hours plan. Threats
included the rejection of 4.5 NP FTEs, business plan approval, and new hospital construction.
Intervention budget. The five-year financial analysis for the intervention is shown as
Appendix L. Labor costs include the type of procedures, such as those performed in the Cath Lab
by the NPs during the extended hours of service, including the provision of device management
support at the time of the MRI. Also reviewed were non-labor costs, such as the amount of time
spent by the staff, administrators, and the DNP student on planning this improvement project.
Based on the financial analysis, 6.5 NPs are required to comply with CMS guidelines and
support twenty-four hours, seven days per week, inpatient and outpatient cases. Two FTEs were
previously approved for the new hospital activation in fall 2019; therefore, the net incremental
request was for 4.5 NP FTEs. The first year anticipated a net loss of $347,396 is due to salaries
and benefits, not fully ramping up with the projected number of procedures, as well as the
frequent interdisciplinary team meetings needed for planning. Years two through five projects an
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average annual net gain of $201,525. It was necessary to demonstrate a positive return on
investment (ROI) to influence key stakeholders to support this quality improvement project.
Measures
The outcome measure was improved MRI access and throughput for patients with
CIEDs, measured by all patients with CIEDs that have active MRI orders, ascertained through
the CBA tool. Those patients were manually cross-referenced with completed procedure notes in
the electronic medical record. The arrhythmia and radiology teams captured this discrete data
through an electronically-generated report.
One process measure was the number of patients turned away from MRI due to a nonconditional CIED, determined through the CIED database, and confirmed by arrhythmia NPs
that the reason for exclusion was due their non-conditional CIED (see Appendix M). A second
process measure was the volume of all patients who have CIEDs and require an MRI. The
AMC’s CBA report and the patient’s electronic medical record were the tools used to measure
volume and determine the number of patients who were deferred an MRI. Through the CBA
report and electronic medical records, the arrhythmia and radiology teams will perform postimplementation completion assessments weekly for one month, monthly for three months,
quarterly for one year, and then yearly thereafter.
Analysis
In the initial assessment and planning of this quality improvement project, gaps in current
practice were identified. Pre-intervention data was collected by performing a retrospective chart
review of all patients who presented with acute neurological conditions, had a CIED, and
required an MRI. Data was collected from the CBA report and the AMC’s data management
application by using diagnosis codes and keywords and a retrospective electronic chart review.
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Microsoft Excel was utilized to capture and compare the data pre- and post-intervention. Deidentified data were extracted from patient medical records and included in the spreadsheet. The
final analysis will include the post-implementation data extracted during the scheduled
monitoring period.
Ethical Considerations
Nursing is based on the foundation of compassion and benevolence for the health and
respect of patients, families, and communities (American Nurses Association [ANA], 2015).
This project supports the ANA code of ethics to formulate and maintain a standard for nurses to
utilize ethical analysis and decision-making. The implementation of extended NP staffing
coverage to manage CIEDs during an MRI demonstrates accountability and responsibility for
nursing practice.
This evidence-based improvement project embodies the Jesuit value of cura personalis,
suggestive of individualizing the care and attention to the whole being (McGinn, 2015). The
goals of this quality-improvement project were to promote patient safety, improve patient
throughput and access, and maintain high standards of care. As a non-research project, it did not
require Institutional Review Board (IRB) approval for implementation. The project was
evaluated and approved as a quality improvement endeavor through the University of San
Francisco School of Nursing and Health Professionals (see Appendix N).
Section IV: Results
Hiring and training 4.5 NP FTEs was critical for the implementation of extended hours of
CIED management support during an MRI, 24 hours per day, seven days per week. The
arrhythmia team has successfully hired two NPs, both with limited cardiovascular health and
CIED experience. Training for the two NPs is expected to be completed between November
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2019 and January 2020. Recruitment continues for the remaining 2.5 NP FTEs. Support will be
provided by extending the hours of service every Monday and Tuesday from 7 am until 11 pm
starting October 7, 2019. Since implementation, the NP has supervised 18 MRIs after 5 pm.
When all 4.5 NP FTEs are hired, the capacity to provide 24 hours per day, seven days per week
accountability in CIED management during an MRI will have been achieved. Based on the CBA
report identifying the volumes of patients with CIEDs requiring an MRI (see Appendix O), it is
imperative that active NP recruitment is continued to fill the necessary positions in order to fully
implement this improvement project and maintain adherence to CMS staffing requirements.
Section V: Discussion
Summary
The aim of the DNP led the evidence-based project in improving MRI access for all
patients with CIEDs through the policy and procedure revision, creation of standardized
workflows, and extension of hours for MRI was achieved. Key findings include the neurology
team’s retrospective chart review from 2017 that established the need for device management
support for patients who present with acute neurological conditions, such as stroke and TIAs and
have non-conditional CIEDs. The findings determined that 2.5 patients per month did not
receive an MRI due to their non-conditional CIEDs. The review concluded that of the CIEDS,
75% were pacemakers, made by one specific vendor. We confirmed that patients with
conditional CIEDs did not receive an MRI due to the misconception that the device was nonconditional. This data was concerning for the physician leaders from neurology, radiology, and
arrhythmia teams and prompted an urgent need to find a solution to provide safe patient care (see
Appendix P).
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Stakeholder recognition of project implication on patient safety and interdisciplinary
collaboration contributed most importantly to the successful changes. Leadership support and
fostering team spirit were essential in achieving favorable outcomes. Integrating the best
available evidence on quality of care, clinical outcomes, and patient satisfaction were necessary
on the impact of advanced practice nursing. The implementation of the NPs in the CIED MRI
management improved patient outcomes, thus impacting the advanced practice nursing role.
Interpretation
The DNP project was guided by the published literature in combination with CMS
requirements and clinical expertise. The findings from the studies were consistent with some of
the literature review and validated the safety of MRI for non-conditional CIEDs at low magnetic
strength. Implementation of the new CIED MRI workflows impacted patient throughput by
providing safety guidelines for the non-conditional CIEDs. The AMC now has the capacity to
provide MRIs for all patients regardless of the conditionality of their CIED.
Limitations
Since this is a non-research study, there are limitations to the generalizability of the
results. Barriers to implementation were concentrated in recruitment, hiring, and training of the
NPs. The arrhythmia team faced challenges to recruit the approved 4.5 NP FTEs. The number of
interested NPs interested who have cardiovascular health experience is extremely
limited. Hiring inexperienced NPs and providing the necessary training was the chosen
alternative, although this strategy introduced additional challenges. The onboarding process,
which includes credentialing, can take three months for each NP. Training inexperienced NPs
could take up to nine months. With each new, inexperienced NP, it will take approximately one
year to gain the competency to work independently. Considering these timelines, the arrhythmia
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team was concerned it could take more than a year before full implementation of extended hours
of service to 24 hours a day, seven days per week for CIED management can be achieved.
Since the arrhythmia team could not hire all the necessary NPs to fully implement the
project, expectations were adjusted. Since March 2019, only three NPs were hired, two with
minimal cardiac and CIED experience. After credentialing, the two NPs with limited experience
will be fully trained between November 2019 and January 2020. Retention of NPs has also been
challenging. One NP who had CIED experience recently resigned. These obstacles will not
change the goal of improving MRI access for patients with CIEDs, but rather adjust how the
arrhythmia team will be providing this service until all the necessary staff have been hired and
trained.
Conclusions
The CVH service line’s goal is to create a value-added framework for the CVH patient
that spans the continuum of care by engaging teams in building a network of care programs thus
improving access, capacity, quality, and patient experience. This quality improvement project
supported the AMC’s pillars of quality, service/patient experience, employee engagement, and
financial strength. By implementing a national staffing model for patients who require an MRI
and have a CIED, the AMC has provided the appropriate care for these patients, minimizing
patient safety concerns, and improving patient service and experience. The collaborative effort
between the arrhythmia, radiology, and neurology departments demonstrated meaningful
development of a positive interdisciplinary working relationship. The arrhythmia NPs and
radiology staff nurses view this project as a double benefit of adding value to patient care and
streamlining workflows. By implementing the CMS national staffing model for patients who
require an MRI and have a CIED, the AMC has provided the appropriate care for these patients,
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minimizing patient safety concerns, and improving patient service and experience. Ensuring the
sustainability of this project will require an ongoing commitment.
Section VI: Other Information
Funding
There were no special funding sources affiliated with this evidence-based quality
improvement project. All resources and time associated with the investigation, development,
implementation, and evaluation were included in the current pay structure and process.
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Limitations:
Data was acquired at a
single center and may
not be generalizable to
other clinical settings
and MRI facilities.
Unable to obtain longterm follow up
information from 302
patients. The study did
not perform
defibrillation testing in
patients who had an
ICD. The numbers of
each individual devices
were small. Interactions
of future systems
cannot be ruled out.
Critical Appraisal Tool
& Rating:
John Hopkins Research
Evidence Appraisal
Tool , II A.
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Citation

Conceptual
Framework

Van der Graaf,
None
A.W.M., Bhagirath,
P., & Gotte, M.J.W.
(2014). MRI and
cardiac implantable
electronic devices;
current status and
required safety
conditions.
Netherlands Heart
Journal , 22, 269276. Retrieved from
http://dx.doi.org/10.
1007/s12471-0140544-x

Design/Method Sample/Setting

Abstract

Variable Studied
and Their
Definitions
This review
6 studies and 4
paper provides clinical trials were
an overview of reviewed.
the currently
available data
related to
CIEDs and MRI
and attempts to
offer an up-to
date and
clinically useful
summary for the
practicing
cardiologist. Six
studies and
four clinical
trials were
reviewed.
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Measurement

Data Analysis

Findings

Appraisal:
Worth to Practice

Reviewed clinical
trials and
numerous
literature to
study the safety
of MRIs and
CIEDs.

An overview of
all available MRI
conditional
devices and their
individual
restrictions was
given.

With
appropriate
monitoring
and
application
of a safety
protocol, MRI
can be safely
performed in
patients with
CIEDs.

Strengths:
This abstract
demonstrated the
MRI safety of
pacemakers and
ICDs.
Limitations:
Data was limited to
the 6 studies and
4clinical trials.
Studies with use of
higher magnetic
strength should have
been included.
Critical Appraisal
Tool & Rating:
John Hopkins
Research Evidence
Appraisal Tool , III
A/B.

EXPANDING MAGNETIC RESONANCE ACCESS
Citation

Conceptual
Framework

Nordbeck, P., None
Ertl, G., &
Ritter, O.
(2015).
Magnetic
resonance
imaging safety
in pacemaker
and
implantable
cardioverter
defibrillator
patients: How
far have we
come?
European
Heart
Journa l, 36,
1501-1511.

Design/Method

Clinical Review
and Update

Sample/Setting
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Variable Studied Measurement Data Analysis
and Their
Definitions

This clinical
Reviewed clinical 14 pacemaker
review provides a trials over the last studies and 13
better
20 years.
ICD studies.
understanding of
the mechanisms
responsible for
life-threatening
complications as
well as technical
advances
allowing an
increasing
number of
pacemakers and
ICDs to safely
undergo MRIs.

14 pacemaker
studies and 13
ICD studies
assessed the
outcome in 1.5T
MR scanners.
There were no
adverse events
reported.

Findings

Appraisal:
Worth to Practice

Appropriate
monitoring and
application
of a safety
protocol, MRIs
can be safely
performed in
patients with
CIEDs.

Strengths:
This review
demonstrated the
MRI safety of
pacemakers and
ICDs.
Limitations:
Data was limited to
14 pacemaker
studies and 13 ICD
studies. Studies
with use of higher
magnetic strength
(>1.5T) should
have been
included.
Critical Appraisal
Tool & Rating:
John Hopkins
Research
Evidence
Appraisal Tool , III
A/B.
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Studies
Author & Year

Russo et al. Yadava et al. Dandamudi Jung,W.,
(2017)
(2017)
et al. (2016) Sebastian,
J.,
Zvereva,
V. (2015)

Viera, M.S., Shenthar et al. Shah et al.
Lazoura, O., (2015)
(2018)
Nicol, E.,
Rubens, M.
& Padley, S.
(2013)
Types of Magnetic Resonance Imaging (MRI)

Thoracic 1.5Tesla

X

X

Spinal 1.5 Tesla

X

X

X

X

Non-thoracic 1.5 Tesla

X

Full body 1.5 Tesla
Utilization of CIED MRI Protocol
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X

X

X
X

X
X

X

Wilkoff et al. Bailey et al. Nazarian et al. Van der Graaf, Nordbeck, P.,
(2011)
(2016)
(2017)
A.W.M.,
Ertl, G., &
Bhagirath, P., & Ritter, O.
Gotte, M.J.W. (2015)
(2014)

X

X

X

X

X
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Type of Cardiovascular Implantable Electronic Device (CIED)
MRI Conditional CIED

X

X

X
X

MRI Non-conditional CIED

X

X

X

CIED Reprogramming

X

X

X

X

X
X

X

X

Single Vendor Specific

X

X

Multi-vendor Specific

X

X

X

X

X

X

Outcomes
Low to No MRI Related
Complications/Adverse Effects

X

X

X

X

X

X

X

X

X

X

X
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Appendix D – Gantt Chart

Spring 2018
Identify DNP Project Problem/Create AIM Statement
Identify stakeholders
Identify b aseline metrics
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Perform literature r eviews
Workflow Development: Inpatient MRI, Outpatient MRI, Urgent
MRI
Project plan draft
Create Work Breakdown Structure
Business p lan d raft
Summer 2018
Finalize p roject p lan
Review business plan with arrhythmia medical director and
business operations director
Update workflows
Update MRI CIED Policy and Procedure
Create EPIC (EMR) Smartphrase MRI CIED Interrogation
Procedure Note
Create CIED Screening Tool
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Fall 2018
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Coordinate Meeting with Stakeholders; present business plan
Present Workflows/Policy and Procedure to Arrhythmia and
Radiology teams
Present business plan proposal to stakeholders
Obtain approval for business plan from Cardiovascular Health and
Radiology Executive Directors and Vice Presidents
IT/EPIC (EMR) initial meeting to discuss electronic workflows
Follow up - IT/EPIC (EMR) regarding electronic workflows
Finalize EPIC Smartphrase MRI CIED Interrogation Procedure Note
Finalize CIED Screening Tool
Spring 2019
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Business plan approval confirmation
IT/EPIC (EMR) confirmation of electronic workflows
Finalize policy and procedure
Confirmation of MRI CIED workflow approval
Confirmation arrhythmia team staffing plan - NP coverage
NP recruitment and hiring
Summer 2019
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Workflow and CIED management education to nurse practitioners,
radiology RNs, radiology techicians, and physicians
New NP onboading and training
Implementation of NP extended hours coverage
Fall 2019
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Monitor outcomes of NP extended hours MRI coverage for CIEDs
Perform PDSA
Evalutate outcome of staffing implementation
Present outcomes

Dec

Nov

Oct

Sep

Aug

Jul

Jun

Apr

May

Mar

Jan

Feb

Dec

Oct

Nov

Sep

Jul

2019

Aug

Jun

Apr

May

Mar

Jan

Feb

2018
Expanding Magnetic Resonance Imaging Access for Patients
with CIEDs
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Appendix F – Electronic Order Sets and Workflows
Cardiology CIED screening form for patients
undergoing MRI

Ordering Physician Name (please print):

Patient Name:

Please fax completed form to MRI
Scheduling (650) 723-6036

Date
and Time:

MR #

DOB:

The patient should be evaluated and reviewed for the following:
Device Name and Model____________
Lead(s) Model: Atrial:_________ RV:_________ LV:__________
Date of device implantation _________________________
Is this MRI conditional system: yes: o
no: o
o No abandoned leads or wires, lead extenders, or lead adapters are present (confirmed with CXR within 2 weeks)
o No broken leads or leads with intermittent electrical contact as confirmed by lead impedance history
o For patients who have multiple MR-Conditional devices, the MR labeling conditions for all implants are satisfied
o
o
o
o
o

Pace polarity parameters set to Bipolar
The device is operating normally and within the projected service life and/or pulse generator has sufficient battery, not at ERI or EOL
In patients whose device will be programmed to an asynchronous pacing mode when MRI scan mode is On: no diaphragmatic
stimulation at a pacing output of 5.0 V and at a pulse width of 1.0 ms
All Lead impedance values ≥ 200 ohms and ≤ 1500 ohms
For Medtronic ICDs: SureScan ICD system: pacing lead impedance value: >200 ohms and <3000 ohms

o
o
o

All Lead capture thresholds: <2V @0.4 msec in devices programmed to asynchronous pacing mode
In BiV devices LV lead pacing impedance of ≥ 200 ohms and ≤ 3000 ohms;
Defibrillation lead impedances between 20 and 200 ohms

o

For Boston Scientific: Patient does not have an elevated body temperature or compromised thermoregulation at the time of the scan

Patient’s intrinsic rhythm is:______________
Patient is pacemaker-dependent: Yes o

Noo

Recommendation for MRI:
Based on the information documented above patient can proceed to have MRI:
Yes o

Noo

Name of the EP RN/CNS/NP completing the form:______________
Date: ___________

______________________________________________________________________________________
For patients with MRI non-conditional CIEDs:
“Patient informed about the potential adverse interactions between the CIED and MRI that may include the inhibition of pacing, CIED warming,
vibration, skin or soft tissue burns, asynchronous pacing, induction of atrial fibrillation, induction of ventricular fibrillation, switch mode
malfunction, rapid atrial stimulation, rapid ventricular stimulation, and alteration in the CIED programming with potential damage to CIED circuit or
system dislocation leading to potential CIED malfunction resulting in potentially life-threatening arrhythmias, heart block, and death”
Provider Name______________________________
Date_____________________
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Please fax completed form to MRI
Scheduling (650) 723-6036

Cardiology Order Set for Pacemaker/ICD programing
for MRI

Ordering Physician Name (please print):

Patient Name:

Date
and Time:

MR #

DOB:

Home Phone:

Work/Cell Phone:

All fields MUST be completed to clear patient for MRI. Incomplete forms will be rejected and sent back.
The Patient was reviewed for the following:
o Device Name and Model_______________________________ Lead(s) Model__________________
o An MR Conditional pacing device has been implanted a minimum of 6 weeks in the left
or right pectoral region post the lead maturation period. Date of device implantation _________________________
o No abandoned leads or wires, lead extenders, or lead adapters are present
o

No broken leads or leads with intermittent electrical contact as confirmed by lead impedance history

o

For patients who have multiple MR-Conditional devices, the MR labeling conditions for all implants are satisfied

o

Pace polarity parameters set to Bipolar

o

The device is operating normally and within the projected service life and/or pulse generator has sufficient battery, not at ERI or EOL

o

No diaphragmatic stimulation at a pacing output of 5.0 V and at a pulse width of 1.0 ms in patients whose device will be programmed to an
asynchronous pacing mode when MRI scan mode is On

o

All Lead impedance value ≥ 200 ohms and ≤ 1500 ohms

o

For Medtronic ICDs : SureScan ICD system: pacing lead impedance value: >200 ohms and <3,000

o

All Lead capture thresholds: <2V @0.4 msec.

o

In BiV devices LV lead pacing impedance of ≥ 200 ohms and ≤ 3000 ohms;

o

Defibrillation lead impedances between 20 and 200 ohms

o

For Boston Scientific: Patient does not have an elevated body temperature or compromised thermoregulation at the time of the scan

Patient can proceed to have MRI: Yes o

Noo

Cardiology orders for device programming:
Prior to MRI:
For MRI conditional Devices:
Medtronic: SureScan mode ON o
St Jude: Confirmed MRI Setting status and the programmed MRI Mode settings o
Boston Scientific: MRI protection Mode ON o
For non-MRI conditional devices:
o Deactivate monitoring and tachyarrhythmia therapies
o Deactivate magnet response, rate response, PVC response, noise response, ventricular sense response and conducted AF
response
Is the patient pacemaker dependent?
o Yes: Program to: DOO oVOO

Pacing Rate: _____bpm

o No: Program to: DDI oVVI
During MRI:
oMonitor blood pressure, EKG, O2 and symptoms during MRI
Post MRI:
oRecheck sensing, impedance and pacing thresholds and compare with baseline
o Restore original programming.
oPost-scan program MRI scan mode to OFF.
oComplete device interrogation documentation in EPIC
Physician/Provider signature_________________
Print name:____________________

Date______________________
Pager_____________________
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CIED MRI Workflows (Inpatient/Outpatient/Urgent)
MRI ordered by primary team. MRI/
Radiology Department identifies
patients with CIED requiring inpatient
MRI

·

·

Inpatient Cardiovascular
Implantable Electronic
Devices/MRI Workflow
Created: R. Geronimo/
A.Tsiperfal Updated 8/6/18

·

MRI Non-conditional CIED
Include all CIED system other
than those that meet MRI
conditional labeling and all
specified conditions of use
No abandoned leads/wires/lead
extenders/lead adapters (Xray
may be required)

Determine conditionality of CIED by
Radiology staff in consultation with
manufacturer

·
·
·

MRI Conditional CIED
Any device for which a specified MRI
environment with specified conditions of
use does not pose a known hazard as
confirmed by manufacturer.
System beyond the exempt period for
conditionality from the time of implant?
Device Implanted minimum of 6 weeks
No abandoned leads/wires/lead extenders/
lead adapters (Xray may be required

MRI department faxes
cardiology checklist/MRI
clearance form to inpatient unit
and instructs to page EP team
at #15590

·

Do not
proceed with
MRI

·
·
Pt not cleared for MRI
·

EP team evaluates patient’s device,
determines dependency, and completes the
MRI/Cardiology checklist/MRI clearance form
EP team deems if pt is cleared for MRI
Ordering provider contacts Dr. Wintermark or
designee to discuss the risk/benefit of MRI for
the pt.
Ordering provider agrees to proceed with MRI
and patient is consented as documented on
clearance form

IP unit to fax
form back to
MRI
department

Pt cleared for MRI

·
·
·

MRI dept arranges for EP team
or Device Rep to manage the
CIED based on conditionality
Device Rep will be notified to
manage the conditional CIED
EP team will be notified by MRI
department to reprogram nonconditional CIED or if Device Rep
is not available for the study 8am
-5pm

Patient arrives
in MRI for MRI
scan

·
·
·

·

MRI staff to provide continuous ECG & pulse oximetry
monitoring from 7am-5pm M-F
EP team to provide continuous device monitoring
pacemaker dependent patients
Defib/monitor with external pacing function and
programmer available in patient holding area and any
resuscitative efforts that involve MR unsafe equipment
would be performed after moving the patient outside zone 4
MRI personnel with skills to perform ACLS in attendance
during the time the patient is reprogrammed and until
assessed and declared stable to return to unmonitored
status.

Device Rep/EP
team to
perform CIED
evaluation
post MRI and
return to prestudy settings

Device Rep/EP
Team
interrogates
and programs
CIED for MRI

·
·

Device Rep/EP team to send
interrogation report to EP team
If EP team not present, MRI staff
in charge of the patient will
document the Device Rep’s
presence and assure completion
of the post-MRI form

EP team
documents
interrogation
in Paceart and
EPIC

EP team uses
smartphrase in
EPIC and labels
encounter
“Pre/Post MRI
CIED Check”

Interrogation
Encounter will
be available
for viewing in
the “Procedure
Tab” in EPIC

·
·

Follow up in Device Clinic 3-6 months after MRI.
Follow up in 1 week if any capture threshold increase >1.0V,
sensing dropped >50%, pacing impedance changed >50% or
shock impedance changed >5 ohms
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MRI/Radiology Department identifies
patients with CIED requiring outpatient
MRI

·

·

MRI Non-conditional CIED
Include all CIED system other
than those that meet MRI
conditional labeling and all
specified conditions of use
No abandoned leads/wires/lead
extenders/lead adapters (Xray
may be required)

Outpatient Cardiovascular
Implantable Electronic
Devices/MRI Workflow
Created: R. Geronimo/
A.Tsiperfal Updated 8/6/18

·

Determine conditionality of CIED by
Radiology staff in consultation with
manufacturer

·
·
·

MRI Conditional CIED
Any device for which a specified MRI
environment with specified conditions of
use does not pose a known hazard as
confirmed by manufacturer.
System beyond the exempt period for
conditionality from the time of implant?
Device Implanted minimum of 6 weeks
No abandoned leads/wires/lead extenders/
lead adapters (Xray may be required

Device interrogation
request sent to “CV
Med Device Team”
pool by MRI Dept:
specify date of study

Device Coordinator to
notify patient and
schedule for in-person
device interrogation in
Outpatient Device
Management Clinic

Patient
evaluated in
device
management
clinic

MRI/Cardiology
checklist/clearance form
completed by EP team
and scanned to HMIS

If conditional CIED

If Non-conditional CIED

MRI study
cannot be
completed at
this time

The MRI dept arranges for
Device Rep to re-program
the device on day of study

Patient arrives
in MRI for
scheduled
appointment

·
·

·

Interrogation Encounter will be
available for viewing in the
“Procedure Tab” in EPIC

·

Device Rep interrogates CIED
If Device Rep not available at
the time of the study,
reschedule MRI

MRI staff in charge of the patient will
document the Device Rep’s presence
and assure completion of the post-MRI
form and scan pre/post device
interrogation form into EPIC or complete
EPIC dotphrase
MRI staff will instruct patient to follow
up in Device Clinic per Device Rep’s
recommendations
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MRI/Radiology Department identifies
patients with conditional CIED requiring
emergent inpatient MRI

·
·
·

Emergent Conditional
Cardiovascular Implantable
Electronic Devices/MRI
Workflow
Created: R. Geronimo/
A.Tsiperfal Updated 1/8/18

Is system beyond the exempt
period for conditionality from
the time of implant?
Device Implanted minimum of 6
weeks
No abandoned leads/wires/lead
extenders/lead adapters (Xray
may be required)

MRI department
faxes cardiology
order form/checklist
to patient’s RN and
instructs to page EP
team at #15590

RN pages EP team
#15590

MRI dept
arranges for
Device Rep to
re-program the
device on day
of study

Is device Rep
available?

No

EP team evaluates
patient’s device and
completes the MRI/
Cardiology order
form/checklist

EP team will be
notified by MRI
department ro
reprogram device
for the study

Patient’s unit
RN to fax form
back to MRI
department

Patient arrives in
MRI for MRI scan

Device Rep/EP Team
interrogates CIED

·

·
·

·
·

·

Device Rep/EP team will program
device to non-pacing mode (OVO/
ODO) or inhibited mode VVI/DDI
with deactivation of advanced or
adaptive features;
If CRT reasonable to program to
asynchronous pacing with rate to
avoid competitive pacing.
If ICD, deactivate tachycardia
detection and therapies

MRI staff to provide continuous ECG & pulse
oximetry monitoring from 7am-5pm M-F
Defib/monitor with external pacing function and
programmer available in patient holding area
and any resuscitative efforts that involve MR
unsafe equipment would be performed after
moving the patient outside zone 4
MRI personnel/EP team with skills to perform
ACLS in attendance during the time the patient
is reprogrammed and until assessed and
declared stable to return to unmonitored status.

Device Rep/EP team
to perform CIED
evaluation post MRI
and return to prestudy settings

Device Rep/EP team
to send
interrogation report
to Device RN

·
·

Follow up in Device Clinic 3-6 months after MRI.
Follow up in 1 week if any capture threshold increase >1.0V,
sensing dropped >50%, pacing impedance changed >50% or
shock impedance changed >5 ohms

Interrogation
Encounter will be
available for viewing
in the “Procedure
Tab” in EPIC

Device RNs uses
smartphrase in EPIC
and labels
encounter “Device
Check”

Device RN
documents
interrogation in
Paceart and EPIC

Yes

Device Rep will
reprogram device
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Appendix G – EP Nurse Practitioner Job Description
ELECTROPHYSIOLOGY NP JOB DESCRIPTION
Our fast-growing Cardiology EP department is currently seeking a Nurse Practitioner or Physician
Assistant to join its prestigious team. The overall responsibility of this EP NP/PA is to provide highquality care to the arrhythmia patients under the supervision of the EP attending.
SUMMARY:
Primary responsibility of this position is to support inpatient hospital services including electrophysiology
patient admissions, rounding, discharges, and EP coverage including admissions, education, discharge
process, and discharge when needed, peri-operative management of patents undergoing EP procedures,
evaluation and management of patients with cardiac arrhythmias, pacemakers, CRT-D, and defibrillators,
and their devices, management of patients with CIEDs during MRI, engage in a consultative care of
hospitalized patients and to collaborate with physicians, fellow, residents, and medical /APP students,
assisting EP MD during device implant procedures and ablation procedures. This position requires
excellent communication skills and the ability to multi-task. Must have a professional, efficient, and
caring attitude and be a cooperative team member, while maintaining and endorsing high clinical
standards in both the outpatient and inpatient settings.
ESSENTIAL DUTIES AND RESPONSIBILITIES:
➢ Performs evaluation and problem identification of patients.
➢ Performs history and physical examination of patients.
➢ Consents patients for electrophysiology procedures.
➢ Writes orders and interprets laboratory data and radiological tests.
➢ Monitors patient status and response to treatments.
➢ Documents findings in the medical record.
➢ Recommends and orders appropriate therapeutic interventions and writes prescriptions for
recommended pharmacologic treatments.
➢ Interacts with consultants as appropriate.
➢ Directs patient and/or family to agencies dealing with specific illnesses/diseases.
➢ Participates in departmental quality assurance, risk management, and compliance efforts.
➢ Discharges patients who require an overnight observation period after electrophysiological device
placements or ablations.
➢ Venous and arterial sheath removal
ELECTROPHYSIOLOGY NP JOB DESCRIPTION:
➢ Participates in daily team rounding, periodic M&M sessions and department conferences/teaching
opportunities.
➢ Perform ICD/PPM interrogations and programming during these clinics and as needed on inpatients.
➢ Perform patient education during clinic for the patients and families of the aforementioned Physicians.
➢ Make appropriate referrals.
➢ Identify patients for research protocols and notify the PI and research coordinator of potential subjects.
EDUCATION:
A master’s degree in nursing and completion of an approved course of study as a nurse practitioner.
Current ANCC certification and CA licensure as an NP is necessary.
PREFERRED:
Two years of Cardiology experience
One year critical care experience
Cardiac experience as an NP Computer Proficiency
Employment Type: Full-Time
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Appendix H – PDSA Process

Plan

Do

1. Observe
implementation of MRI
CIED workflows.
2. Observe
implementation of NP
extended staffing
model.

1. Create backup
staffing plan.

Act

Study

1. Confirm patient data
and identify gap(s).
2. Implement new
staffing plan.

1. Monitor patients
turned away for MRIs
2. Identify patients
with CIEDs
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Appendix I - Work Breakdown Structure

Level 1

1.0

Expanding MRI
Access for
Patients with
CIEDs

Level 2
1.1

1.2

Plan and
oversee

Level 3

1.3

Budget/
Business Plan

1.4

Education

1.1.1 Develop
Project Plan

1.2.1 Identify
accountability

1.3.1 Peform
Literature
Reviews

1.1.2 Create
Project Charter

1.2.2 Propose
staffing needs

1.3.2 Create
presentation of
findings

1.1.3 Create A3

1.2.3 Define
projected volumes

1.3.3 Coordinate
educational
sessions

1.1.4 Coordinate
Meetings

1.2.4 Define
cost per unit of
service

1.3.4 Prepare
educational
presentations

1.2.5 Identify cost
to implement

1.3.5 Review needs

1.5

Resources

1.4.1 Review
HRS workflow
and CMS staffing
recommendations
1.4.2 Compare
other
organizational
staffing/
workflows

1.4.3 Confirm
approval of
business plan

1.6

Staff

1.5.1
Recruit
and hire
NPs
1.5.2 Propose
scheduling of
staff
1.5.3 Onboarding
and training of
new NPs
1.5.4 Propose
on-call
schedule
1.5.5 Vet
schedules with
team and
stakeholders

Implementation
of intervention

1.6.1 Confirm NP
extended hours
schedule
1.6.2 Review
workflows
1.6.3 Monitor
intervention;
PDSA if needed
1.6.4 Compare
data pre/post
intervention
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Appendix J – Responsibility/Communication Matrix

Project Charter
Project Name

Expand MRI Access for Patients with CIEDs

Problem Statement

Arrhythmia Service would like to partner with the Radiology and Neurology Services to improve MRI access for patients with CIEDs.

Project Scope

Create standardized workflows for conditional and non-conditional CIEDs.
Create business plan to support the CMS staffing standards for CIED management during MRIs.
Obtain physician support to implement the standardized workflows.
Create policy and procedure for MRI CIED management
#
1

2
Metrics
3

4

Project Benefits

Description

Potential Barriers/Risks

Current

0%

2.5/month

100%

100%

100%

90%

Create policy and procedure for MRI
CIED management

100%

80%

Rose G/Angela T

Rose G/Angela T

Rose G/Angela T

Improved staff engagement
Improved health outcomes
Improved transitions of care
Improved patient satisfaction

Team Sponsors: S.S.; S.W.; C.K.; D.K.;
P.W.; M.W.
Team Leader: Rose Geronimo

Accountability
Neuro team

Identify patients who presented with
acute neurological conditions who
have non-conditional CIEDs.
Create standardized workflows for
conditional and non-conditional
CIEDs.
Create business plan to support the
CMS staffing standards for CIED
management during MRIs.

Sponsor(s), Team Leader, Performance
Excellence Lead
Team Members

Target

Team Members:
A.T.

T.N.
R.R.
No budget - competing priorities (new hospital construction
Physician support
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Appendix K – SWOT Analysis

Expanding Access to Magnetic Resonance Imaging for Patients with
CIEDs
SWOT Analysis
Strengths
Improve patient throughput
Improve patient satisfaction
NPs will provide evaluation of appropriateness of the
MRI procedure
Promote patient safety
Revenue generating

Creation of policy and procedure
Development of staffing plan to improve patient
flow
NPs will provide device management for patients
with CIEDs undergoing an MRI
Compliance with CMS guidelines
Development of electronic documentation
workflows

Weaknesses
Serving only neurological patients

Opportunities
Expand service for all patients with CIEDs

Creation of extended hours plan versus 24
hours/7 days per week coverage plan

Threats
Nurse Practitioner FTE approval
Budget approval

Organization competing priorities (i.e.: new
hospital construction)
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Appendix L – Budget/Financial Analysis

Nurse Practitioner Procedures

Year 1
Phase 1

Year 2

Year 3

Year 4

Year 5

416
$4,976,327
$940,038
$485,103
$454,935
$405,772

416
$5,324,670
$968,239
$507,205
$461,034
$410,397

Phase 2

Cardioversion (8/week)
Target Volume at Full Ramp Up = 416
Charge
Net Revenue (19% reiumbursement)
Direct Cost (Including salaries and benefits)
Contribution Margin
Operating Margin

208
$2,031,083
$430,134
$318,600
$111,534
$89,039

Ramp Up
416
$4,346,517
$886,076
$443,833
$442,243
$395,903

MRI (22 conditional & non-conditional/week)
Target Volume at Full Ramp Up = 1144
Charge
Net Revenue (19% reiumbursement)
Direct Cost (Including salaries and benefits)
Contribution Margin
Operating Margin

572
1144
1144
1144
1144
$9,758,978 $20,884,212 $22,346,107 $23,910,335 $25,584,058
$2,066,714 $4,257,432 $4,385,155 $4,516,709 $4,652,210
$2,031,104 $3,456,229 $3,591,150 $3,731,680 $3,878,066
$35,611
$801,202
$794,004
$785,029
$774,145
($423,934) ($145,460)
($181,058)
($219,285)
($260,299)

416
$4,650,773
$912,658
$463,995
$448,663
$400,933

Total Operating Margin

($334,896)

$250,442

$219,875

$186,487

$150,098

Total Incremental FTEs

6

8

8

8

8

Cost of Meetings
Executive Leaders - VPs and Executive Directors (2 VPs/2 ED/4 qaurterly meetings) = $200/hr
Physician Leaders (3 MDs/6 meetings) = $250/hr
Managers/Nurse Practitioners (3 Managers/1 NP/12 meetings for 1st year; 2 meetings 2nd
year) = $100/hr
Equipment - CIED Programmers (2) - Provided by vendor
Net Gain (Loss)

$3,200
$4,500
$4,800
0
($347,396)

0

0
0

0
0

0
0

$800
0

0
0

0
0

0
0

$249,642

$219,875

$186,487

$150,098
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Appendix M – Outcome Measures
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Appendix N – Statement of Non-Research Determination Form
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EXPANDING MAGNETIC RESONANCE ACCESS
Appendix O – Clinical Business Analytics Report – CIED MRI Volumes

2019 ALL CIED MRI VOLUMES

2019 NEURO CIED MRI VOLUMES
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Appendix P – Neurology Study
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